Grifols BioMat USA Plasma Center, a 22,689 SF single tenant mission critical medical building leased by a subsidiary of Grifols (NASDAQ-GRFS & BMAD-GRF) a $16.5 Billion Multinational Specialty Biopharmaceutical Company. Originally built in 1973, ownership completely overhauled the building in 2008 with significant capital expenditure renovations. The tenant subsequently invested over $2,700,000 in specialty medical improvements for its use of the property.